464 related articles for article (PubMed ID: 18302908)
1. Lycopene in the prevention of prostate cancer.
Dahan K; Fennal M; Kumar NB
J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
[TBL] [Abstract][Full Text] [Related]
2. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
Mohanty NK; Saxena S; Singh UP; Goyal NK; Arora RP
Urol Oncol; 2005; 23(6):383-5. PubMed ID: 16301113
[TBL] [Abstract][Full Text] [Related]
3. Lycopene and prostate cancer.
Barber NJ; Barber J
Prostate Cancer Prostatic Dis; 2002; 5(1):6-12. PubMed ID: 15195123
[TBL] [Abstract][Full Text] [Related]
4. Drug Insight: lycopene in the prevention and treatment of prostate cancer.
Guns ES; Cowell SP
Nat Clin Pract Urol; 2005 Jan; 2(1):38-43. PubMed ID: 16474575
[TBL] [Abstract][Full Text] [Related]
5. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.
Peters U; Leitzmann MF; Chatterjee N; Wang Y; Albanes D; Gelmann EP; Friesen MD; Riboli E; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):962-8. PubMed ID: 17507623
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer: agents and study designs.
Thompson IM
J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
[TBL] [Abstract][Full Text] [Related]
7. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
8. Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes.
Goyal A; Delves GH; Chopra M; Lwaleed BA; Cooper AJ
BJU Int; 2006 Oct; 98(4):907-11. PubMed ID: 16978292
[TBL] [Abstract][Full Text] [Related]
9. Lycopene: modes of action to promote prostate health.
Wertz K; Siler U; Goralczyk R
Arch Biochem Biophys; 2004 Oct; 430(1):127-34. PubMed ID: 15325920
[TBL] [Abstract][Full Text] [Related]
10. Lycopene effects contributing to prostate health.
Wertz K
Nutr Cancer; 2009; 61(6):775-83. PubMed ID: 20155615
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
Pathak SK; Sharma RA; Mellon JK
Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of prostate cancer.
Klein EA
Crit Rev Oncol Hematol; 2005 Apr; 54(1):1-10. PubMed ID: 15780904
[TBL] [Abstract][Full Text] [Related]
13. [Nutrition and pharmacological treatment for prevention of prostate cancer].
Segev Y; Nativ O
Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
[TBL] [Abstract][Full Text] [Related]
14. Target populations and strategies for chemoprevention trials of prostate cancer.
Bostwick DG
J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
[TBL] [Abstract][Full Text] [Related]
15. Lycopene in cancer prevention and treatment.
Seren S; Lieberman R; Bayraktar UD; Heath E; Sahin K; Andic F; Kucuk O
Am J Ther; 2008; 15(1):66-81. PubMed ID: 18223356
[TBL] [Abstract][Full Text] [Related]
16. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
Fujimoto N; Chang C; Nomura M; Matsumoto T
Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A, retinoids and carotenoids as chemopreventive agents for prostate cancer.
Kristal AR
J Urol; 2004 Feb; 171(2 Pt 2):S54-8; discussion S58. PubMed ID: 14713755
[TBL] [Abstract][Full Text] [Related]
19. Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study.
Barber NJ; Zhang X; Zhu G; Pramanik R; Barber JA; Martin FL; Morris JD; Muir GH
Prostate Cancer Prostatic Dis; 2006; 9(4):407-13. PubMed ID: 16983396
[TBL] [Abstract][Full Text] [Related]
20. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.
Schwenke C; Ubrig B; Thürmann P; Eggersmann C; Roth S
J Urol; 2009 Mar; 181(3):1098-103. PubMed ID: 19150092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
